logo
Select company
Select metric
$ 0Interest Expense
VS
Market
69
Sector
59
Industry
47
History
-
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

SAGE

Company Name

SAGE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SAGE THERAPEUTICS INC - Interest Expense Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SAGE - Int. Exp. Historical data
DateInterest Expense
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SAGE THERAPEUTICS INC's latest trailing twelve months (TTM) Int. Exp. stands at $ 0.
  • Over the past 5 years, SAGE THERAPEUTICS INC's average Int. Exp. has been $ 0.
  • The median Int. Exp. for SAGE THERAPEUTICS INC during this period was $ 0
  • SAGE THERAPEUTICS INC reached its highest Int. Exp. over the past 5 years at $ 0.
  • The lowest Int. Exp. recorded by SAGE THERAPEUTICS INC in the same timeframe $ 0

SAGE THERAPEUTICS INC's Int. Exp. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Int. Exp. Benchmarks
CompanyInt. Exp.
KURA : KURA ONCOLOGY INC $ 1.59MTBPH : THERAVANCE BIOPHARMA INC $ 2.58MNKTR : NEKTAR THERAPEUTICS $ 26.54MZVRA : ZEVRA THERAPEUTICS INC $ 8.48MLXRX : LEXICON PHARMACEUTICALS INC $ 12.57MADCT : ADC THERAPEUTICS SA $ 50.26MYMAB : Y-MABS THERAPEUTICS INC $ -4.03MGOSS : GOSSAMER BIO INC $ 10.96MEYPT : EYEPOINT PHARMACEUTICALS INC $ 14KAUTL : AUTOLUS THERAPEUTICS PLC $ -16.84M

Definition of Interest Expense

[Income Statement] Interest expense is the cost incurred by a business for borrowing funds.

SAGE - Interest Expense, Last 5 years

$ 0

Minimum

Sep 30, 2020

$ 0

Maximum

Sep 30, 2020

$ 0

Average

$ 0

Median

Int. Exp. Benchmark Analysis

The chart above depicts the distribution of Int. Exp. for companies in the Total Stock Market. The average Int. Exp. of the companies is $ 2.75M with a standard deviation of $ 5.5M.
The following table provides additional summary stats:
Int. Exp. in the Market:
filtered constituents2.72K
min$ -15.41M
max$ 22.87M
average$ 2.75M
median$ 17.64K
std$ 5.5M